The Mounjaro 5mg Pen: What Actually Happens at This Stage of Treatment

You've just been told you're moving to 5mg, here's what that actually means

Imagine you're a few weeks into treatment. The 2.5mg pen went better than you feared: some queasiness after the first injection, a little less appetite by week three. Now the repeat review has come back and your prescriber has moved you to 5mg. It's a natural question to wonder what, if anything, will feel different.

The 5mg pen contains the same tirzepatide molecule as the starter pen, but at double the dose. The 2.5mg phase exists largely to let your body adjust to the medicine; 5mg is where treatment begins in earnest. Many people notice appetite suppression becoming more pronounced at this point, smaller portions feel satisfying sooner, and interest in food between meals fades. That said, individual responses vary considerably, and a prescriber's job is partly to interpret those differences. You can read about the full picture of how Mounjaro works as a treatment if the mechanism is something you want to understand more deeply.

Each KwikPen contains four weekly doses, so one 5mg pen covers a full month. Injection sites rotate between the abdomen, thigh, and upper arm. Storage is the same as the starter pen: refrigerated at 2–8°C. For the exact room-temperature window if you're travelling or away from a fridge, the Mounjaro Patient Information Leaflet is the right source, the window is specific and worth checking directly rather than relying on what you remember being told.

Side effects at 5mg: the pattern most people experience

Dose increases are the moments when side effects are most noticeable, and the step from 2.5mg to 5mg is no exception. The NHS tirzepatide patient page lists the most common reactions: nausea, loose stools or constipation, indigestion, burping, and fatigue. For most people these are mild to moderate and ease off within a week or two as the body settles at the new dose.

A few practical things tend to help: eating slowly, choosing smaller and plainer meals for the first week or so, keeping fluid intake up, and not lying down immediately after eating. None of that is a substitute for your own prescriber's advice, but it reflects what people commonly find useful.

One side effect worth knowing about specifically: pancreatitis. The MHRA issued a Drug Safety Update in January 2026 noting that, while infrequent, acute pancreatitis is a recognised risk with GLP-1 medicines. Severe, persistent stomach pain that radiates to the back (with or without vomiting) warrants urgent medical attention, not a wait-and-see approach. Report any suspected side effects through the MHRA Yellow Card scheme. Your prescriber remains the first call for anything that concerns you during treatment.

Pregnancy, breastfeeding, and trying to conceive are all situations where tirzepatide is not recommended. Under-18s are outside the licensed population. If your circumstances change at any point, let your clinical team know.

The 5mg pen and contraception: a detail people sometimes miss

This comes up more than you might expect. If you take an oral contraceptive pill, MHRA guidance advises adding a non-oral method (condoms, for example) for the first four weeks of starting Mounjaro and for four weeks after each dose increase. The reason is that tirzepatide slows gastric emptying, which can affect how reliably an oral medicine is absorbed. At 5mg, if this is your first increase, that four-week window applies again. It's the kind of detail that's easy to overlook in the middle of a dose change, so our prescribers flag it routinely. For a fuller view of how to approach contraception alongside treatment, the NHS England guidance on weight-management injections sets out the position clearly.

Women using HRT may also want to discuss transdermal options (patches or gels rather than oral tablets) with their doctor for the same absorption reason. Surgery, including planned elective procedures, is another situation to flag: your anaesthetist and surgical team need to know you are taking tirzepatide before any procedure.

Cost, access and the question of next steps

Understanding where the 5mg pen fits is one thing; knowing how to access it through a legitimate, clinically supervised route is another. The 5mg dose page covers access specifics in more detail. If you're transferring from another provider and already on 5mg, you will need to provide evidence of your current treatment, that is standard clinical practice, not a hurdle unique to any particular pharmacy.

People researching costs sometimes arrive wanting to know whether they can reduce the price by sourcing a dose independently, and if you've noticed Mounjaro's price has increased recently, you're not alone in looking closely at that question. That question has a straightforward answer: Mounjaro is a prescription-only medicine, and any supply without a valid prescription from a registered prescriber falls outside the law. The realistic cost picture for Mounjaro in the UK explains what private treatment actually includes and why headline prices between providers can differ. One transparent price that covers consultation, prescription, and tracked delivery is worth comparing carefully against any figure that leaves those components out.

If you're still considering whether treatment is right for you, the weight-loss treatment overview sets out the landscape. And if you'd like a prescriber to look at your specific situation, start your free consultation, a real clinician reviews it, typically the same day.